US EditionNovo Holdings appoints four new members to its Board of Directors further strengthening global perspectives and strategic capabilities – Optimum Strategic CommunicationsLink to: Heidelberg Pharma to Present Promising New Clinical Data on its Lead ATAC Can
Summary by Optimum Strategic Communications
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Novo Holdings appoints four new members to its Board of Directors further strengthening global perspectives and strategic capabilities – Optimum Strategic CommunicationsLink to: Heidelberg Pharma to Present Promising New Clinical Data on its Lead ATAC Can
May 15, 2025 – Novo Holdings is pleased to announce the appointments of Jun Sung Kim, Lars Green, N.P. “Narv” Narvekar and Torsten Sløk to its Board of Directors, effective May 14, 2025. These distinguished leaders bring a broad range of investment expertise spanning both U.S. and international markets, further strengthening the Board’s global perspectives […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage